Prosecution Insights
Last updated: October 01, 2026
Application No. 18/844,457

SURGICAL SMOKE FILTERING DEVICE

Non-Final OA §102
Filed
Sep 06, 2024
Priority
Mar 09, 2022 — provisional 63/318,315 +1 more
Examiner
ZINK, AMANDA L
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Covidien L.P.
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
580 granted / 681 resolved
+15.2% vs TC avg
Minimal +3% lift
Without
With
+3.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
13 currently pending
Career history
695
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
41.6%
+1.6% vs TC avg
§102
27.9%
-12.1% vs TC avg
§112
9.1%
-30.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 681 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 11-19 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected group II, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 01/20/2026. Applicant’s election without traverse of group I, claims 1-10 and 20 in the reply filed on 01/20/2026 is acknowledged. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-10 and 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kellner (US 2017/0303964). Regarding claim 1, Kellner discloses a surgical smoke filtering device, comprising: an annular collar defining a longitudinally-extending central passageway configured to be placed over an incision (view figure 1 with central passageway defined by channel 50); a plurality of apertures (perforations 56) disposed through an inner surface of the annular collar and configured to receive surgical smoke therethrough; a first electrode (negative charge plate 47) disposed within a first annular channel defined by the annular collar, the first electrode having a first electrical charge; and a second electrode (positively charged collection plate 62) disposed within a second annular channel defined by the annular collar and having a second electrical charge opposite the first electrical charge, the first and second electrodes configured to generate an airflow to draw the surgical smoke through the annular collar for filtering particulates from the surgical smoke [Para 0015-0018]. Regarding claim 2, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first and second electrodes are annular (view figure 1; [Para 0015-0018]). Regarding claim 3, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the annular collar is configured to be coupled to an access device, the access device configured to be at least partially inserted through the incision (view figure 1; [Para 0015-0018]). Regarding claim 4, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first and second electrodes coaxially surround the longitudinally-extending central passageway (view figure 1; [Para 0015-0018]). Regarding claim 5, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first annular channel is in fluid communication with the plurality of apertures disposed through the inner surface of the annular collar (view figure 1; [Para 0015-0018]). Regarding claim 6, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first annular channel is in fluid communication with the second annular channel (view figure 1; [Para 0015-0018]). Regarding claim 7, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first electrode is negatively charged, and the second electrode is positively charged (view figure 1; [Para 0015-0018]). Regarding claim 8, Kellner discloses the surgical smoke filtering device according to claim 7, wherein the first electrode is configured to apply a negative charge to the particulates contained within the surgical smoke, and the particulates negatively charged by the first electrode are configured to attach to the positively charged second electrode (view figure 1; [Para 0015-0018]). Regarding claim 9, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the annular collar includes an outlet configured to operably couple to a source of suction (view figure 1; [Para 0019]). Regarding claim 10, Kellner discloses the surgical smoke filtering device according to claim 1, wherein the first and second annular channels coaxially surround the longitudinally-extending central passageway (view figure 1; [Para 0015-0018]). Regarding claim 20, Kellner discloses a surgical smoke filtering device, comprising: an annular collar defining a longitudinally-extending central passageway configured to be placed over an incision (view figure 1 with central passageway defined by channel 50); a plurality of apertures (perforations 56) disposed through a surface of the annular collar and configured to receive surgical smoke therethrough; a first electrode (negative charge plate 47) disposed within the annular collar and coaxially surrounding the longitudinally-extending central passageway; and a second electrode (positively charged collection plate 62) disposed within the annular collar and coaxially surrounding the longitudinally-extending central passageway, the first and second electrodes configured to cause particulates contained within the surgical smoke to attach to one of the first or second electrodes to filter the particulates from the surgical smoke (view figure 1 and [Para 0015-0018]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Worrell (US 2015/0080876), Fleenor (US2016/0278874) both disclose smoke evacuation devices. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMANDA L ZINK whose telephone number is (571)270-7103. The examiner can normally be reached Monday-Friday 7-12 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne Hoffman can be reached at (303)297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.L.Z/Examiner, Art Unit 3794 /MICHAEL F PEFFLEY/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Sep 06, 2024
Application Filed
Sep 04, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740826
SYSTEMS, APPARATUSES, AND METHODS FOR PRE-ABLATION PULSES IN PULSED FIELD ABLATION APPLICATIONS
4y 2m to grant Granted Sep 22, 2026
Patent 12740818
METHOD, DEVICE, AND SYSTEM FOR PRE-BIASED TISSUE WITH LOWER-ENERGY IRREVERSIBLE ELECTROPORATION AND TISSUE IDENTIFICATION FOR PULSE FIELD IMMUNOTHERAPY
1y 11m to grant Granted Sep 22, 2026
Patent 12727931
ELECTROSURGICAL SYSTEM WITH SUCTION CONTROL APPARATUS, SYSTEM AND METHOD
4y 2m to grant Granted Sep 08, 2026
Patent 12708766
SELECTIVE MODULATION OF INTRACELLULAR EFFECTS OF CELLS USING PULSED ELECTRIC FIELDS
4y 1m to grant Granted Aug 18, 2026
Patent 12702474
APPARATUS AND METHOD FOR DELIVERY AND MONITORING OF ABLATION THERAPY
4y 7m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
88%
With Interview (+3.1%)
3y 3m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 681 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month